Structure

Physi-Chem Properties

Molecular Weight:  406.04
Volume:  357.39
LogP:  4.343
LogD:  3.687
LogS:  -4.129
# Rotatable Bonds:  3
TPSA:  80.49
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.344
Synthetic Accessibility Score:  3.329
Fsp3:  0.05
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.148
MDCK Permeability:  4.779477421834599e-06
Pgp-inhibitor:  0.004
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.017
20% Bioavailability (F20%):  0.061
30% Bioavailability (F30%):  0.566

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.117
Plasma Protein Binding (PPB):  97.9762954711914%
Volume Distribution (VD):  0.908
Pgp-substrate:  1.47665274143219%

ADMET: Metabolism

CYP1A2-inhibitor:  0.929
CYP1A2-substrate:  0.22
CYP2C19-inhibitor:  0.955
CYP2C19-substrate:  0.061
CYP2C9-inhibitor:  0.905
CYP2C9-substrate:  0.909
CYP2D6-inhibitor:  0.956
CYP2D6-substrate:  0.653
CYP3A4-inhibitor:  0.949
CYP3A4-substrate:  0.267

ADMET: Excretion

Clearance (CL):  3.261
Half-life (T1/2):  0.519

ADMET: Toxicity

hERG Blockers:  0.685
Human Hepatotoxicity (H-HT):  0.174
Drug-inuced Liver Injury (DILI):  0.598
AMES Toxicity:  0.035
Rat Oral Acute Toxicity:  0.96
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.185
Carcinogencity:  0.021
Eye Corrosion:  0.003
Eye Irritation:  0.023
Respiratory Toxicity:  0.897

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470323

Natural Product ID:  NPC470323
Common Name*:   [5-(6-Bromo-1H-Indol-3-Yl)-1H-Imidazol-2-Yl]-(4,5-Dihydro-1H-Indol-3-Yl)Methanone
IUPAC Name:   [5-(6-bromo-1H-indol-3-yl)-1H-imidazol-2-yl]-(4,5-dihydro-1H-indol-3-yl)methanone
Synonyms:  
Standard InCHIKey:  JBAPNYOAPKFPKK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C20H15BrN4O/c21-11-5-6-13-14(8-23-17(13)7-11)18-10-24-20(25-18)19(26)15-9-22-16-4-2-1-3-12(15)16/h2,4-10,22-23H,1,3H2,(H,24,25)
SMILES:  C1CC2=C(C=C1)NC=C2C(=O)C3=NC=C(N3)C4=CNC5=C4C=CC(=C5)Br
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL198074
PubChem CID:   44404473
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[15921415]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[16154746]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. n.a. n.a. PMID[17253840]
NPO32581 spongosorites sp. Species Halichondriidae Eukaryota n.a. southern australian n.a. PMID[9599272]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1821 Individual Protein Sortase Staphylococcus aureus IC50 > 100.0 ug.mL-1 PMID[508936]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 100.0 ug.mL-1 PMID[508936]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470323 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9854 High Similarity NPC935
0.9854 High Similarity NPC267078
0.9807 High Similarity NPC474357
0.9223 High Similarity NPC267811
0.8756 High Similarity NPC473218
0.8756 High Similarity NPC470702
0.8744 High Similarity NPC116555
0.8714 High Similarity NPC470703
0.8494 Intermediate Similarity NPC77101
0.8182 Intermediate Similarity NPC237414
0.8044 Intermediate Similarity NPC156003
0.795 Intermediate Similarity NPC63109
0.7943 Intermediate Similarity NPC326422
0.7857 Intermediate Similarity NPC474180
0.7857 Intermediate Similarity NPC188821
0.784 Intermediate Similarity NPC477004
0.7793 Intermediate Similarity NPC474389
0.7689 Intermediate Similarity NPC304203
0.7633 Intermediate Similarity NPC307191
0.7615 Intermediate Similarity NPC317701
0.7593 Intermediate Similarity NPC153123
0.7593 Intermediate Similarity NPC474318
0.7593 Intermediate Similarity NPC475914
0.7593 Intermediate Similarity NPC220797
0.7593 Intermediate Similarity NPC268744
0.7593 Intermediate Similarity NPC201266
0.7573 Intermediate Similarity NPC284775
0.756 Intermediate Similarity NPC110158
0.7558 Intermediate Similarity NPC77241
0.7558 Intermediate Similarity NPC269203
0.7558 Intermediate Similarity NPC166209
0.7558 Intermediate Similarity NPC13456
0.7548 Intermediate Similarity NPC191415
0.7467 Intermediate Similarity NPC282247
0.743 Intermediate Similarity NPC476460
0.7393 Intermediate Similarity NPC108011
0.7346 Intermediate Similarity NPC102755
0.7339 Intermediate Similarity NPC167710
0.7339 Intermediate Similarity NPC74619
0.7273 Intermediate Similarity NPC19696
0.7273 Intermediate Similarity NPC136957
0.7261 Intermediate Similarity NPC475736
0.726 Intermediate Similarity NPC174281
0.726 Intermediate Similarity NPC475286
0.726 Intermediate Similarity NPC477611
0.7251 Intermediate Similarity NPC16659
0.7238 Intermediate Similarity NPC473380
0.7238 Intermediate Similarity NPC240088
0.723 Intermediate Similarity NPC477003
0.7222 Intermediate Similarity NPC231536
0.7204 Intermediate Similarity NPC265710
0.7198 Intermediate Similarity NPC474195
0.719 Intermediate Similarity NPC474958
0.7184 Intermediate Similarity NPC17751
0.7184 Intermediate Similarity NPC274229
0.7149 Intermediate Similarity NPC474196
0.7149 Intermediate Similarity NPC37152
0.7129 Intermediate Similarity NPC82331
0.7101 Intermediate Similarity NPC69843
0.7064 Intermediate Similarity NPC324091
0.7059 Intermediate Similarity NPC476526
0.7059 Intermediate Similarity NPC329765
0.7059 Intermediate Similarity NPC48117
0.7042 Intermediate Similarity NPC200553
0.7042 Intermediate Similarity NPC279189
0.7034 Intermediate Similarity NPC229893
0.7014 Intermediate Similarity NPC252572
0.7005 Intermediate Similarity NPC470203
0.7004 Intermediate Similarity NPC82053
0.7 Intermediate Similarity NPC477167
0.7 Intermediate Similarity NPC54981
0.7 Intermediate Similarity NPC304187
0.7 Intermediate Similarity NPC477166
0.7 Intermediate Similarity NPC473342
0.6983 Remote Similarity NPC174489
0.6982 Remote Similarity NPC128244
0.6971 Remote Similarity NPC247987
0.6971 Remote Similarity NPC317105
0.697 Remote Similarity NPC471194
0.697 Remote Similarity NPC471193
0.6968 Remote Similarity NPC19342
0.6959 Remote Similarity NPC99939
0.6959 Remote Similarity NPC308931
0.6957 Remote Similarity NPC470204
0.6955 Remote Similarity NPC162002
0.6951 Remote Similarity NPC201831
0.6951 Remote Similarity NPC17487
0.6948 Remote Similarity NPC151635
0.6938 Remote Similarity NPC42372
0.6933 Remote Similarity NPC106771
0.6933 Remote Similarity NPC23420
0.6933 Remote Similarity NPC303820
0.6933 Remote Similarity NPC205254
0.6932 Remote Similarity NPC471536
0.6926 Remote Similarity NPC26641
0.6923 Remote Similarity NPC477108
0.6923 Remote Similarity NPC477109
0.6923 Remote Similarity NPC253687
0.6923 Remote Similarity NPC477107
0.6923 Remote Similarity NPC216550
0.6912 Remote Similarity NPC21429
0.6906 Remote Similarity NPC79356
0.6906 Remote Similarity NPC102592
0.6903 Remote Similarity NPC94211
0.6903 Remote Similarity NPC52909
0.6903 Remote Similarity NPC475935
0.6901 Remote Similarity NPC280297
0.6884 Remote Similarity NPC233050
0.6884 Remote Similarity NPC276540
0.6878 Remote Similarity NPC141926
0.687 Remote Similarity NPC476525
0.687 Remote Similarity NPC476524
0.687 Remote Similarity NPC71238
0.6857 Remote Similarity NPC280864
0.6853 Remote Similarity NPC72956
0.6852 Remote Similarity NPC88110
0.6851 Remote Similarity NPC477114
0.6844 Remote Similarity NPC97902
0.684 Remote Similarity NPC97343
0.6835 Remote Similarity NPC467063
0.6831 Remote Similarity NPC207686
0.6824 Remote Similarity NPC153980
0.6824 Remote Similarity NPC6865
0.6822 Remote Similarity NPC293216
0.6822 Remote Similarity NPC317054
0.682 Remote Similarity NPC243381
0.682 Remote Similarity NPC275292
0.6815 Remote Similarity NPC171393
0.6815 Remote Similarity NPC295452
0.6808 Remote Similarity NPC54214
0.6798 Remote Similarity NPC473761
0.6794 Remote Similarity NPC122141
0.6789 Remote Similarity NPC117027
0.678 Remote Similarity NPC27041
0.6773 Remote Similarity NPC135601
0.6773 Remote Similarity NPC63571
0.6773 Remote Similarity NPC476527
0.6773 Remote Similarity NPC17273
0.6773 Remote Similarity NPC141612
0.6751 Remote Similarity NPC469717
0.6742 Remote Similarity NPC310633
0.6741 Remote Similarity NPC88315
0.6737 Remote Similarity NPC471192
0.673 Remote Similarity NPC274981
0.6727 Remote Similarity NPC133003
0.6727 Remote Similarity NPC476341
0.6726 Remote Similarity NPC227582
0.6721 Remote Similarity NPC235685
0.6718 Remote Similarity NPC117980
0.6712 Remote Similarity NPC103119
0.6709 Remote Similarity NPC82370
0.6699 Remote Similarity NPC216643
0.6698 Remote Similarity NPC115232
0.6697 Remote Similarity NPC111566
0.6694 Remote Similarity NPC63031
0.6694 Remote Similarity NPC101350
0.6682 Remote Similarity NPC471943
0.6682 Remote Similarity NPC157583
0.6681 Remote Similarity NPC477413
0.668 Remote Similarity NPC130570
0.6667 Remote Similarity NPC474492
0.6667 Remote Similarity NPC88115
0.6667 Remote Similarity NPC74413
0.6667 Remote Similarity NPC470677
0.6652 Remote Similarity NPC266249
0.6652 Remote Similarity NPC210123
0.6652 Remote Similarity NPC106757
0.6638 Remote Similarity NPC252338
0.6637 Remote Similarity NPC473666
0.6636 Remote Similarity NPC270834
0.6635 Remote Similarity NPC325903
0.6634 Remote Similarity NPC288838
0.6622 Remote Similarity NPC272458
0.6621 Remote Similarity NPC314281
0.6621 Remote Similarity NPC40530
0.6607 Remote Similarity NPC154339
0.6602 Remote Similarity NPC469811
0.6597 Remote Similarity NPC36405
0.6596 Remote Similarity NPC123839
0.6594 Remote Similarity NPC81535
0.6588 Remote Similarity NPC135141
0.6588 Remote Similarity NPC92796
0.658 Remote Similarity NPC260900
0.6574 Remote Similarity NPC227489
0.6574 Remote Similarity NPC476421
0.6574 Remote Similarity NPC28096
0.6573 Remote Similarity NPC206148
0.6573 Remote Similarity NPC149265
0.657 Remote Similarity NPC321911
0.6562 Remote Similarity NPC321708
0.6561 Remote Similarity NPC470205
0.6557 Remote Similarity NPC470680
0.6557 Remote Similarity NPC100104
0.6553 Remote Similarity NPC143872
0.6553 Remote Similarity NPC63545
0.655 Remote Similarity NPC131887
0.655 Remote Similarity NPC67288
0.6549 Remote Similarity NPC47190
0.6545 Remote Similarity NPC73994
0.6545 Remote Similarity NPC79777

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470323 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8294 Intermediate Similarity NPD2008 Discontinued
0.8148 Intermediate Similarity NPD2411 Approved
0.7963 Intermediate Similarity NPD2443 Approved
0.7963 Intermediate Similarity NPD2442 Approved
0.7844 Intermediate Similarity NPD1600 Suspended
0.7834 Intermediate Similarity NPD1506 Discontinued
0.7814 Intermediate Similarity NPD2879 Approved
0.7814 Intermediate Similarity NPD2881 Approved
0.7763 Intermediate Similarity NPD2408 Discontinued
0.7689 Intermediate Similarity NPD460 Discontinued
0.7671 Intermediate Similarity NPD3905 Phase 3
0.7489 Intermediate Similarity NPD6470 Phase 3
0.7465 Intermediate Similarity NPD1982 Phase 1
0.7464 Intermediate Similarity NPD1895 Discontinued
0.7455 Intermediate Similarity NPD4863 Approved
0.7419 Intermediate Similarity NPD2880 Discontinued
0.7366 Intermediate Similarity NPD2295 Clinical (unspecified phase)
0.7295 Intermediate Similarity NPD3347 Clinical (unspecified phase)
0.7269 Intermediate Similarity NPD8458 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD8488 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD8258 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD8256 Approved
0.7217 Intermediate Similarity NPD8257 Approved
0.7193 Intermediate Similarity NPD7657 Approved
0.7193 Intermediate Similarity NPD7656 Approved
0.7189 Intermediate Similarity NPD1658 Discontinued
0.7182 Intermediate Similarity NPD1952 Discontinued
0.7182 Intermediate Similarity NPD5446 Phase 2
0.7143 Intermediate Similarity NPD2364 Suspended
0.7129 Intermediate Similarity NPD1567 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD6579 Phase 2
0.7119 Intermediate Similarity NPD6715 Discontinued
0.7083 Intermediate Similarity NPD2793 Discontinued
0.7082 Intermediate Similarity NPD5199 Approved
0.7082 Intermediate Similarity NPD5198 Approved
0.7078 Intermediate Similarity NPD3431 Approved
0.7078 Intermediate Similarity NPD3430 Approved
0.7069 Intermediate Similarity NPD5643 Phase 2
0.7059 Intermediate Similarity NPD7023 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD4649 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD2930 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD4541 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD4299 Phase 1
0.7035 Intermediate Similarity NPD6229 Phase 2
0.7025 Intermediate Similarity NPD6986 Phase 1
0.7017 Intermediate Similarity NPD6164 Phase 2
0.7017 Intermediate Similarity NPD6165 Phase 2
0.7013 Intermediate Similarity NPD4341 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD2363 Discontinued
0.7012 Intermediate Similarity NPD8047 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD5962 Phase 2
0.6987 Remote Similarity NPD7704 Clinical (unspecified phase)
0.6983 Remote Similarity NPD4395 Phase 1
0.6979 Remote Similarity NPD6210 Phase 3
0.6978 Remote Similarity NPD6837 Clinical (unspecified phase)
0.6974 Remote Similarity NPD3840 Phase 2
0.6974 Remote Similarity NPD3839 Phase 2
0.6972 Remote Similarity NPD2009 Clinical (unspecified phase)
0.6967 Remote Similarity NPD3360 Clinical (unspecified phase)
0.696 Remote Similarity NPD7209 Approved
0.696 Remote Similarity NPD7208 Approved
0.696 Remote Similarity NPD7207 Approved
0.6951 Remote Similarity NPD5831 Discontinued
0.6947 Remote Similarity NPD4924 Clinical (unspecified phase)
0.693 Remote Similarity NPD6271 Approved
0.69 Remote Similarity NPD7445 Phase 1
0.6889 Remote Similarity NPD5854 Approved
0.688 Remote Similarity NPD2412 Clinical (unspecified phase)
0.6878 Remote Similarity NPD4854 Phase 3
0.6872 Remote Similarity NPD2333 Discontinued
0.686 Remote Similarity NPD8317 Phase 2
0.686 Remote Similarity NPD8316 Phase 2
0.6856 Remote Similarity NPD4023 Clinical (unspecified phase)
0.6849 Remote Similarity NPD5001 Clinical (unspecified phase)
0.6849 Remote Similarity NPD3378 Clinical (unspecified phase)
0.6847 Remote Similarity NPD1896 Approved
0.6846 Remote Similarity NPD5415 Approved
0.6844 Remote Similarity NPD7459 Phase 2
0.6844 Remote Similarity NPD6465 Phase 2
0.6806 Remote Similarity NPD3341 Clinical (unspecified phase)
0.6798 Remote Similarity NPD4872 Clinical (unspecified phase)
0.6797 Remote Similarity NPD6459 Phase 2
0.6786 Remote Similarity NPD5853 Phase 3
0.6786 Remote Similarity NPD5855 Phase 3
0.6777 Remote Similarity NPD1313 Approved
0.6766 Remote Similarity NPD6481 Clinical (unspecified phase)
0.6763 Remote Similarity NPD5887 Clinical (unspecified phase)
0.6756 Remote Similarity NPD1871 Approved
0.6756 Remote Similarity NPD6278 Clinical (unspecified phase)
0.6756 Remote Similarity NPD2316 Clinical (unspecified phase)
0.6753 Remote Similarity NPD6328 Clinical (unspecified phase)
0.6747 Remote Similarity NPD7857 Phase 3
0.6747 Remote Similarity NPD7856 Phase 2
0.6743 Remote Similarity NPD1707 Approved
0.6743 Remote Similarity NPD1708 Approved
0.6741 Remote Similarity NPD3485 Clinical (unspecified phase)
0.6741 Remote Similarity NPD2446 Approved
0.6741 Remote Similarity NPD2445 Approved
0.6732 Remote Similarity NPD3811 Discontinued
0.6726 Remote Similarity NPD3419 Clinical (unspecified phase)
0.6726 Remote Similarity NPD6180 Clinical (unspecified phase)
0.6719 Remote Similarity NPD6458 Discontinued
0.6712 Remote Similarity NPD1332 Clinical (unspecified phase)
0.6712 Remote Similarity NPD5016 Approved
0.6708 Remote Similarity NPD7887 Approved
0.6708 Remote Similarity NPD7888 Approved
0.6707 Remote Similarity NPD6970 Phase 2
0.6697 Remote Similarity NPD4940 Approved
0.6696 Remote Similarity NPD4615 Phase 2
0.6695 Remote Similarity NPD2819 Clinical (unspecified phase)
0.6695 Remote Similarity NPD1996 Discontinued
0.6694 Remote Similarity NPD3786 Phase 3
0.6682 Remote Similarity NPD5685 Approved
0.6682 Remote Similarity NPD3607 Clinical (unspecified phase)
0.6682 Remote Similarity NPD5686 Approved
0.6682 Remote Similarity NPD2457 Phase 2
0.6682 Remote Similarity NPD5145 Clinical (unspecified phase)
0.6682 Remote Similarity NPD2456 Phase 2
0.668 Remote Similarity NPD3914 Clinical (unspecified phase)
0.668 Remote Similarity NPD2400 Phase 2
0.6667 Remote Similarity NPD4988 Discontinued
0.6667 Remote Similarity NPD2392 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4446 Approved
0.6653 Remote Similarity NPD5985 Phase 2
0.6652 Remote Similarity NPD6269 Clinical (unspecified phase)
0.6652 Remote Similarity NPD5462 Discontinued
0.6652 Remote Similarity NPD6268 Phase 1
0.664 Remote Similarity NPD8159 Discontinued
0.6639 Remote Similarity NPD5465 Phase 2
0.6638 Remote Similarity NPD5491 Phase 3
0.6638 Remote Similarity NPD5489 Phase 1
0.6638 Remote Similarity NPD3265 Phase 1
0.6637 Remote Similarity NPD7406 Phase 2
0.6637 Remote Similarity NPD8641 Approved
0.6627 Remote Similarity NPD3962 Phase 2
0.6627 Remote Similarity NPD3959 Phase 2
0.6625 Remote Similarity NPD5827 Discontinued
0.6624 Remote Similarity NPD3860 Discontinued
0.6623 Remote Similarity NPD6468 Clinical (unspecified phase)
0.6623 Remote Similarity NPD6469 Phase 3
0.6622 Remote Similarity NPD4922 Phase 2
0.6622 Remote Similarity NPD2591 Phase 2
0.6621 Remote Similarity NPD1291 Clinical (unspecified phase)
0.6621 Remote Similarity NPD5508 Phase 1
0.662 Remote Similarity NPD1333 Phase 3
0.6612 Remote Similarity NPD7661 Clinical (unspecified phase)
0.6608 Remote Similarity NPD2960 Clinical (unspecified phase)
0.6604 Remote Similarity NPD1016 Phase 2
0.6604 Remote Similarity NPD1015 Phase 2
0.6596 Remote Similarity NPD4051 Discontinued
0.6589 Remote Similarity NPD2478 Clinical (unspecified phase)
0.6589 Remote Similarity NPD8484 Phase 2
0.6581 Remote Similarity NPD6520 Phase 3
0.6581 Remote Similarity NPD6521 Phase 3
0.6579 Remote Similarity NPD3830 Phase 1
0.6575 Remote Similarity NPD3432 Approved
0.6568 Remote Similarity NPD4614 Clinical (unspecified phase)
0.6565 Remote Similarity NPD6816 Phase 3
0.6559 Remote Similarity NPD7172 Approved
0.6559 Remote Similarity NPD7173 Approved
0.655 Remote Similarity NPD465 Clinical (unspecified phase)
0.6547 Remote Similarity NPD2872 Phase 2
0.6547 Remote Similarity NPD4426 Clinical (unspecified phase)
0.6547 Remote Similarity NPD6721 Phase 1
0.6547 Remote Similarity NPD4902 Discontinued
0.654 Remote Similarity NPD4352 Phase 1
0.6538 Remote Similarity NPD8493 Clinical (unspecified phase)
0.6537 Remote Similarity NPD4318 Clinical (unspecified phase)
0.6537 Remote Similarity NPD4142 Discontinued
0.6535 Remote Similarity NPD3362 Clinical (unspecified phase)
0.6535 Remote Similarity NPD4848 Phase 1
0.653 Remote Similarity NPD3041 Approved
0.6528 Remote Similarity NPD2875 Clinical (unspecified phase)
0.6527 Remote Similarity NPD4851 Clinical (unspecified phase)
0.6525 Remote Similarity NPD7809 Clinical (unspecified phase)
0.6525 Remote Similarity NPD5072 Discontinued
0.6524 Remote Similarity NPD6288 Clinical (unspecified phase)
0.652 Remote Similarity NPD6265 Discontinued
0.6518 Remote Similarity NPD3246 Discontinued
0.6515 Remote Similarity NPD5270 Discontinued
0.6512 Remote Similarity NPD2311 Clinical (unspecified phase)
0.6511 Remote Similarity NPD2510 Approved
0.6511 Remote Similarity NPD2509 Approved
0.6504 Remote Similarity NPD7709 Discontinued
0.6502 Remote Similarity NPD4298 Clinical (unspecified phase)
0.65 Remote Similarity NPD2813 Phase 3
0.65 Remote Similarity NPD2812 Clinical (unspecified phase)
0.6494 Remote Similarity NPD8248 Clinical (unspecified phase)
0.6492 Remote Similarity NPD3960 Clinical (unspecified phase)
0.6488 Remote Similarity NPD5884 Clinical (unspecified phase)
0.6484 Remote Similarity NPD4558 Phase 2
0.6484 Remote Similarity NPD2367 Phase 2
0.6484 Remote Similarity NPD8523 Approved
0.6478 Remote Similarity NPD1249 Clinical (unspecified phase)
0.6476 Remote Similarity NPD5973 Phase 2
0.6476 Remote Similarity NPD5974 Approved
0.6475 Remote Similarity NPD6849 Phase 2
0.6475 Remote Similarity NPD6850 Phase 2
0.6473 Remote Similarity NPD5642 Approved
0.6473 Remote Similarity NPD5820 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data